Recent Advances in the Psychopharmacology of Major Depressive Disorder.

IF 1.7 Q3 PSYCHIATRY
BJPsych Advances Pub Date : 2023-03-01 Epub Date: 2022-04-04 DOI:10.1192/bja.2022.14
Laith Alexander, Allan H Young
{"title":"Recent Advances in the Psychopharmacology of Major Depressive Disorder.","authors":"Laith Alexander, Allan H Young","doi":"10.1192/bja.2022.14","DOIUrl":null,"url":null,"abstract":"<p><p>This review highlights some of the recent advances in the psychopharmacology of Major Depressive Disorder (MDD). We synthesise evidence on emerging pharmacological therapies targeting the serotonergic system, before exploring several novel treatment targets: the glutamatergic system, the GABAergic system, and inflammation. When describing new treatment avenues, we examine the evidence base and how far these new treatments are from routine practice.</p>","PeriodicalId":9336,"journal":{"name":"BJPsych Advances","volume":"58 1","pages":"117-130"},"PeriodicalIF":1.7000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7617086/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJPsych Advances","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1192/bja.2022.14","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

This review highlights some of the recent advances in the psychopharmacology of Major Depressive Disorder (MDD). We synthesise evidence on emerging pharmacological therapies targeting the serotonergic system, before exploring several novel treatment targets: the glutamatergic system, the GABAergic system, and inflammation. When describing new treatment avenues, we examine the evidence base and how far these new treatments are from routine practice.

重度抑郁症的精神药理学研究进展。
本文综述了重性抑郁症(MDD)精神药理学研究的最新进展。我们综合了针对血清素能系统的新兴药理疗法的证据,然后探索了几个新的治疗靶点:谷氨酸能系统、gaba能系统和炎症。在描述新的治疗途径时,我们检查了证据基础以及这些新治疗离常规实践有多远。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BJPsych Advances
BJPsych Advances PSYCHIATRY-
CiteScore
2.50
自引率
7.70%
发文量
75
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信